Literature DB >> 23511487

Systematic review of transition from adolescent to adult care in patients with sickle cell disease.

Lanetta Jordan1, Paul Swerdlow, Thomas D Coates.   

Abstract

Awareness and practice of appropriate treatment for childhood sickle cell disease (SCD) has improved, and survival rates have increased significantly. Today, most patients will eventually require treatment in the adult-care setting. Adolescents who are transferred out from successful pediatric programs face numerous challenges regarding continuity of care, and mortality rates remain high in this age group. Here, we describe a systematic literature review conducted to examine the barriers to and approaches for successful transition of patients with SCD from adolescent to adult care. Articles were primarily located through the US National Library of Medicine (Pubmed.gov) and were omitted if their principal focus was not SCD transition treatment. A secondary search of 5 additional sources was conducted regarding relevant guidelines or meta-analyses. Current publications describe barriers to continuity of care in this group, proposals for improving the transition process, and contemporary models for SCD care transition. Clinical recommendations include development of a flexible, patient-centric transition plan and education for health care providers.

Entities:  

Mesh:

Year:  2013        PMID: 23511487     DOI: 10.1097/MPH.0b013e3182847483

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  21 in total

1.  Applicability of the SMART Model of Transition Readiness for Sickle-Cell Disease.

Authors:  Siddika S Mulchan; Jessica M Valenzuela; Lori E Crosby; Claudia Diaz Pow Sang
Journal:  J Pediatr Psychol       Date:  2015-12-30

2.  Association between hospital admissions and healthcare provider communication for individuals with sickle cell disease.

Authors:  Robert M Cronin; Manshu Yang; Jane S Hankins; Jeannie Byrd; Brandi M Pernell; Adetola Kassim; Patricia Adams-Graves; Alexis A Thompson; Karen Kalinyak; Michael DeBaun; Marsha Treadwell
Journal:  Hematology       Date:  2020-12       Impact factor: 2.269

3.  Nonhematopoietic Nrf2 dominantly impedes adult progression of sickle cell anemia in mice.

Authors:  Samit Ghosh; Chibueze A Ihunnah; Rimi Hazra; Aisha L Walker; Jason M Hansen; David R Archer; Amma T Owusu-Ansah; Solomon F Ofori-Acquah
Journal:  JCI Insight       Date:  2016-04-07

4.  A preliminary investigation of the psychometric properties of PROMIS® scales in emerging adults with sickle cell disease.

Authors:  Aimee K Hildenbrand; Charles T Quinn; Constance A Mara; James L Peugh; Emily A McTate; Maria T Britto; Lori E Crosby
Journal:  Health Psychol       Date:  2019-05       Impact factor: 4.267

5.  Perceptions of young adults with sickle cell disease concerning their disease experience.

Authors:  Nadine Matthie; Jill Hamilton; Diana Wells; Coretta Jenerette
Journal:  J Adv Nurs       Date:  2015-09-09       Impact factor: 3.187

6.  Role of self-care in sickle cell disease.

Authors:  Nadine Matthie; Coretta Jenerette; Susan McMillan
Journal:  Pain Manag Nurs       Date:  2014-10-31       Impact factor: 1.929

Review 7.  Clinical review: Diabetes in the adolescent: transitional issues.

Authors:  Sarah K Lyons; Ingrid M Libman; Mark A Sperling
Journal:  J Clin Endocrinol Metab       Date:  2013-10-23       Impact factor: 5.958

Review 8.  Management of adolescents with congenital adrenal hyperplasia.

Authors:  Deborah P Merke; Dix P Poppas
Journal:  Lancet Diabetes Endocrinol       Date:  2013-11-15       Impact factor: 32.069

9.  Needs Assessment for Patients with Sickle Cell Disease in South Carolina, 2012.

Authors:  Alyssa M Schlenz; Andrea D Boan; Daniel T Lackland; Robert J Adams; Julie Kanter
Journal:  Public Health Rep       Date:  2016 Jan-Feb       Impact factor: 2.792

10.  Sickle-Cell Disease Co-Management, Health Care Utilization, and Hydroxyurea Use.

Authors:  Nancy Crego; Christian Douglas; Emily Bonnabeau; Marian Earls; Kern Eason; Elizabeth Merwin; Gary Rains; Paula Tanabe; Nirmish Shah
Journal:  J Am Board Fam Med       Date:  2020 Jan-Feb       Impact factor: 2.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.